日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Analyzing and evaluating the metabolic and endocrine characteristics between lean and obese patients with polycystic ovary syndrome: a systemic review and meta-analysis

分析和评价多囊卵巢综合征中瘦型和肥胖型患者的代谢和内分泌特征:系统评价和荟萃分析

Zheng, Caiyu; Lin, Yuhao; Zhang, Zhijun; Ye, Jiawen; Lin, Yanmei; Tian, Jianqing

Human milk-derived 5'-UMP promotes thermogenesis and mitochondrial biogenesis to ameliorate obesity

人乳来源的5'-UMP促进产热和线粒体生物合成,从而改善肥胖。

Ling Zhang # ,Zhou Peng # ,Caiyu Lin ,Haixia Hu ,Juan Du ,Siqi Huang ,Shan Huang ,Jianfang Gao ,Xirong Guo

Understanding the dynamics of TKI-induced changes in the tumor immune microenvironment for improved therapeutic effect

了解TKI诱导的肿瘤免疫微环境变化的动态以改善治疗效果

Conghua Lu #, Ziyuan Gao #, Di Wu #, Jie Zheng #, Chen Hu, Daijuan Huang, Chao He, Yihui Liu, Caiyu Lin, Tao Peng, Yuanyao Dou, Yimin Zhang, Fenfen Sun, Weiling Jiang, Guoqing Yin, Rui Han, Yong He

Sialyltransferase ST3GAL4 confers osimertinib resistance and offers strategies to overcome resistance in non-small cell lung cancer

唾液酸转移酶 ST3GAL4 导致奥希替尼耐药性,并提供了克服非小细胞肺癌耐药性的策略

Rui Han, Caiyu Lin, Conghua Lu, Yubo Wang, Jun Kang, Chen Hu, Yuanyao Dou, Di Wu, TingTing He, Huan Tang, Jie Zheng, Li Li, Yong He

Mesoporous manganese nanocarrier target delivery metformin for the co-activation STING pathway to overcome immunotherapy resistance

介孔锰纳米载体靶向递送二甲双胍以共激活 STING 通路克服免疫治疗耐药性

Yuanyao Dou, Jie Zheng, Jun Kang, Liping Wang, Daijuan Huang, Yihui Liu, Chao He, Caiyu Lin, Conghua Lu, Di Wu, Rui Han, Li Li, Liling Tang, Yong He

Metformin promotes anti-tumor immunity in STK11 mutant NSCLC through AXIN1-dependent upregulation of multiple nucleotide metabolites

二甲双胍通过 AXIN1 依赖的多种核苷酸代谢物上调来促进 STK11 突变 NSCLC 中的抗肿瘤免疫

Zhiguo Wang, Kunlin Li, Conghua Lu, Mingxia Feng, Caiyu Lin, Guofang Yin, Dan Luo, Wenyi Liu, Kaiyu Jin, Yuanyao Dou, D I Wu, Jie Zheng, Kejun Zhang, L I Li, Xianming Fan

The potential therapeutic regimen for overcoming resistance to osimertinib due to rare mutations in NSCLC

克服非小细胞肺癌罕见突变导致的奥希替尼耐药性的潜在治疗方案

Rui Han, Caiyu Lin, Chong Zhang, Jun Kang, Conghua Lu, Yiming Zhang, Yubo Wang, Chen Hu, Yong He

Protective autophagy decreases lorlatinib cytotoxicity through Foxo3a-dependent inhibition of apoptosis in NSCLC

保护性自噬通过 Foxo3a 依赖性抑制 NSCLC 细胞凋亡降低洛拉替尼的细胞毒性

Conghua Lu #, Rui Yu #, Chong Zhang, Caiyu Lin, Yuanyao Dou, Di Wu, Yonghong Pan, Tao Peng, Huan Tang, Rui Han, Yong He

Ibrutinib reverses IL-6-induced osimertinib resistance through inhibition of Laminin α5/FAK signaling

伊布替尼通过抑制层粘连蛋白 α5/FAK 信号传导逆转 IL-6 诱导的奥希替尼耐药性

Li Li #, Zhujun Li #, Conghua Lu #, Jianghua Li, Kejun Zhang, Caiyu Lin, Xiaolin Tang, Zhulin Liu, Yimin Zhang, Rui Han, Yubo Wang, Mingxia Feng, Yuan Zhuang, Chen Hu, Yong He

Metformin Combining PD-1 Inhibitor Enhanced Anti-Tumor Efficacy in STK11 Mutant Lung Cancer Through AXIN-1-Dependent Inhibition of STING Ubiquitination

二甲双胍联合 PD-1 抑制剂通过 AXIN-1 依赖性抑制 STING 泛素化增强 STK11 突变肺癌的抗肿瘤功效

Zhiguo Wang, Conghua Lu, Kejun Zhang, Caiyu Lin, Fang Wu, Xiaolin Tang, Di Wu, Yuanyao Dou, Rui Han, Yubo Wang, Chao Hou, Qin Ouyang, Mingxia Feng, Yong He, Li Li